Featured Research

from universities, journals, and other organizations

Artificial pancreas gets first U. S. Outpatient test

Date:
May 14, 2012
Source:
University of Virginia Health System
Summary:
The first U.S. outpatient trial of an artificial pancreas could make it easier for type 1 diabetes patients to manage their condition.

The University of Virginia School of Medicine has launched the first U.S. outpatient trial of a UVA-developed artificial pancreas that could make it easier for type 1 diabetes patients to manage their condition.

A research team led by Patrick Keith-Hynes, PhD, and Boris Kovatchev, PhD, reconfigured a smartphone into a hand-held device to monitor a patient's insulin pump and continuous glucose monitor (CGM). The device is intended to automate much of the work of monitoring and maintaining safe blood sugar levels now performed by patients such as 40-year-old Charlottesville resident Justin Wood, the first patient to participate in the UVA outpatient trial.

Living with type 1 diabetes

Diagnosed as having type 1 diabetes about 28 years ago, Wood uses an insulin pump to help regulate his blood sugar but must check his blood sugar by pricking his finger at least three to five times daily. He also needs to precisely estimate his food consumption -- especially the amount of carbohydrates -- to help properly adjust his insulin supply.

While managing his diabetes is largely second nature, Wood says, "It's something you think about -- either in the back of your mind or the forefront of your mind -- almost constantly."

Automating diabetes care

Wood tested a new approach when he checked into a Charlottesville hotel the night of April 19 for his two-day outpatient trial. He immediately liked the device. "The operating interface was very slick and very fast," he says. "The extra second or two you save pressing buttons adds up when you have to do it every day."

Beginning the following morning, Wood used the device to automatically read and balance his blood sugar level. At mealtimes -- as with his standard insulin pump -- he entered what he ate to help balance his blood sugar quicker. He came away impressed with the potential of the artificial pancreas.

"The device automates a lot of the tracking and monitoring I do now," he says. Wood estimated he could reduce the number of times he pricked his finger for blood sugar tests from at least three to five per day to no more than two a day. He sees the artificial pancreas as "a step forward in technology that could change my view and outlook on life." For Kovatchev, the outpatient trial was a significant change from previous inpatient trials at UVA where patients were monitored in a hospital room. "To see no visible medical items around the patient -- it was an amazing feeling to have."

Next steps in testing

The UVA team and other participants in the JDRF's Artificial Pancreas Project -- the University of California, Santa Barbara; Montpellier University Hospital in France; and the Universities of Padova and Pavia in Italy -- will continue outpatient testing through 2013 at UVA and three other locations. Researchers plan to enroll a total of 120 patients in the trial.


Story Source:

The above story is based on materials provided by University of Virginia Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Virginia Health System. "Artificial pancreas gets first U. S. Outpatient test." ScienceDaily. ScienceDaily, 14 May 2012. <www.sciencedaily.com/releases/2012/05/120514104301.htm>.
University of Virginia Health System. (2012, May 14). Artificial pancreas gets first U. S. Outpatient test. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2012/05/120514104301.htm
University of Virginia Health System. "Artificial pancreas gets first U. S. Outpatient test." ScienceDaily. www.sciencedaily.com/releases/2012/05/120514104301.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins